Prokidney (PROK) EBITDA Margin (2024 - 2026)

Prokidney's (PROK) quarterly EBITDA Margin came in at 19881.86% in Q1 2026, down 188708.0% year-on-year from N/an in Q1 2025, and up 1.4% on a QoQ basis from 20164.89% in Q4 2025.

Prokidney (PROK) EBITDA Margin (2024 - 2026) Analysis & Trends

Prokidney (PROK) has 3 years of EBITDA Margin data on file, last reported at 19881.86% in Q1 2026.

  • On a quarterly basis, EBITDA Margin fell 188708.0% year-over-year to 19881.86% in Q1 2026; TTM through Mar 2026 was 18959.73%, a 4149386.0% increase from a year earlier, with the FY2025 full-year figure at 18477.83%, up 22320112.0% from the prior year.
  • EBITDA Margin for Q1 2026 stood at 19881.86%, up from 20164.89% in the prior quarter.
  • Over the last five years, EBITDA Margin for PROK reached as high as 17759.91% in Q3 2025 and fell as low as 67856.58% in Q4 2024.
  • Historically, EBITDA Margin has averaged 26937.65% across 3 years, with a median of 18938.32% in 2025.
  • Across the five-year window, EBITDA Margin surged 4769169 bps in 2025 and tumbled 188708 bps in 2026, its largest moves.
  • Year by year, EBITDA Margin stood at 67856.58% in 2024, then jumped by 70 bps to 20164.89% in 2025, then grew by 1 bps to 19881.86% in 2026.
  • Per Business Quant data, the three most recent EBITDA Margin figures were 19881.86% in Q1 2026, 20164.89% in Q4 2025, and 17759.91% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Oculis Holding AG 66,831.58 Bn 66,831.30 Bn - -
2 Nanobiotix 1,916.61 Bn 1,916.55 Bn - -
3 Akari Therapeutics 976.78 Bn 976.78 Bn - -
4 BeOne Medicines 471.48 Bn 466.69 Bn 1.35 Bn 16.51%
5 Vertex Pharmaceuticals 121.78 Bn 114.53 Bn 2.59 Bn 38.10%
6 Regeneron Pharmaceuticals 69.87 Bn 61.12 Bn 3.31 Bn 17.83%
7 Belite Bio 63.06 Bn 63.06 Bn - -
8 Argenx Se 55.78 Bn 50.60 Bn 1.41 Bn 31.68%
9 Alnylam Pharmaceuticals 37.54 Bn 34.53 Bn 959.66 Mn 23.02%
10 Prokidney 96.31 Mn 96.31 Mn - -19,881.86%

Historic Data

Download Data
DateValue
Mar 31, 2026 -19,881.86%
Dec 31, 2025 -20,164.89%
Sep 30, 2025 -17,759.91%
Jun 30, 2025 -17,967.87%
Mar 31, 2025 -17,994.78%
Dec 31, 2024 -67,856.58%